A study published in The Lancet Microbe journal reveals a novel approach to studying the progression of tuberculosis (TB) from infection to disease. The study uses PET-CT imaging and a new blood test called the Actiphage assay to identify and treat individuals at high risk of developing TB.
A study published in The Lancet Microbe journal reveals a novel approach to studying the progression of tuberculosis (TB) from infection to disease. The study uses PET-CT imaging and a new blood test called the Actiphage assay to identify and treat individuals at high risk of developing TB.
टिप्पणियाँ
एक टिप्पणी भेजें